Succeeding an enormous wave of investor interest in the healthcare sector, five pharma companies have decided to tap into the initial public offering (IPO) market over the next couple of weeks in order to raise over Rs 8,000 crore.

The list includes the Rs 4,000-crore IPO by the Bain Capital-backed Emcure Pharma, the Rs 1,500-crore issue by Vijaya Diagnostic Centre, diagnostic firms Krsnaa Diagnostics (Rs 1,200 crore) and Mumbai-based bulk drugs maker Supriya Lifesciences (Rs 1,200 crore), and pharma formulations contract development and manufacturer (CDMO) Windlass Biotech's Rs 400 crore issue.

Leave a Reply

Your email address will not be published. Required fields are marked *

Succeeding an enormous wave of investor interest in the healthcare sector, five pharma companies have decided to tap into the initial public offering (IPO) market over the next couple of weeks in order to raise over Rs 8,000 crore.

The list includes the Rs 4,000-crore IPO by the Bain Capital-backed Emcure Pharma, the Rs 1,500-crore issue by Vijaya Diagnostic Centre, diagnostic firms Krsnaa Diagnostics (Rs 1,200 crore) and Mumbai-based bulk drugs maker Supriya Lifesciences (Rs 1,200 crore), and pharma formulations contract development and manufacturer (CDMO) Windlass Biotech's Rs 400 crore issue.

Leave a Reply

Your email address will not be published. Required fields are marked *